YAP1 and prostate carcinoma: In other words, the positive responding breast lines appeared to downregulate HIPPO signaling relative to the negative responders, and this was inconsistent with the pattern observed and expected for the PC3 prostate cancer cells, which are known to positively respond to force and activate YAP, a negative effector of HIPPO signaling.